BRAF-mutations in non-small cell lung cancer

被引：63
|
作者：
Brustugun, Odd Terje [1 ,2 ]
Khattak, Asma Malik [3 ]
Tromborg, Anette Kjoshagen [3 ]
Beigi, Marzieh [3 ]
Beiske, Klaus [3 ]
Lund-Iversen, Marius [3 ]
Helland, Aslaug [1 ,2 ]
机构：
[1] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Oncol, N-0310 Oslo, Norway
[2] Univ Oslo, Inst Clin Med, Oslo, Norway
[3] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Pathol, N-0310 Oslo, Norway
来源：
LUNG CANCER | 2014年 / 84卷 / 01期
关键词：
EGFR-mutation; BRAF-mutation; Genetic testing; Lung cancer; Tyrosine kinase inhibitors; ADENOCARCINOMAS; FEATURES; PATIENT;
D O I：
10.1016/j.lungcan.2014.01.023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Objectives: Targeted therapies in non-small cell lung cancer (NSCLC) now also include inhibitors against mutated BRAF. We present clinicopathological characteristics of nearly one thousand unselected NSCLC patients tested for the targetable V600E/K BRAF-mutation. Material and methods: NSCLC routinely tested for EGFR-mutations at Oslo University Hospital in the period February 2011-July 2013 were tested for V600E/K BRAF-mutations using a PCR-based method. Results: We found a BRAF-mutation frequency of 1.7% in the total cohort of 979 patients, and 23% among 646 adenocarcinomas. One of the BRAF-positive samples was also KRAS-mutated, and one had an ALK-translocation. None of 231 squamous cell carcinomas were BRAF-mutated. The proportion of never-smokers among BRAF-positives was high (29%). Conclusion: BRAF-mutation analysis should be part of the subtyping of non-squamous NSCLC. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：36 / 38
页数：3
相关论文
共 50 条
  • [1] BRAF mutations in non-small cell lung cancer
    Luk, Peter P.
    Yu, Bing
    Ng, Chiu Chin
    Mercorella, Belinda
    Selinger, Christina
    Lum, Trina
    Kao, Steven
    O'Toole, Sandra A.
    Cooper, Wendy A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (02) : 142 - 148
  • [2] Targeting BRAF mutations in non-small cell lung cancer
    O'Leary, Connor Gerard
    Andelkovic, Vladamir
    Ladwa, Rahul
    Pavlakis, Nick
    Zhou, Caicun
    Hirsch, Fred
    Richard, Derek
    O'Byrne, Kenneth
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 1119 - 1124
  • [3] A literature review of a meta-analysis of BRAF mutations in non-small cell lung cancer
    Chimbangu, Clint Taonaishe
    Xi, Li
    Ya, Zhou
    Jiayue, Zhao
    Xiao, Meng
    Ying, Wang
    Xingxu, Yu
    Liu, Xiaomei
    MEDICINE, 2024, 103 (08) : E34654
  • [4] Clinical Significance of BRAF Gene Mutations in Patients with Non-small Cell Lung Cancer
    Kobayashi, Masashi
    Sonobe, Makoto
    Takahashi, Tsuyoshi
    Yoshizawa, Akihiko
    Ishikawa, Masashi
    Kikuchi, Ryutaro
    Okubo, Kenichi
    Huang, Cheng-Long
    Date, Hiroshi
    ANTICANCER RESEARCH, 2011, 31 (12) : 4619 - 4623
  • [5] BRAF Mutations in Non-Small-Cell Lung Cancer
    Smit, Egbert
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (11) : 1594 - 1595
  • [6] Germline mutations predisposing to non-small cell lung cancer
    Clamon, Gerald H.
    Bossler, Aaron D.
    Abu Hejleh, Taher
    Furqan, Muhammad
    FAMILIAL CANCER, 2015, 14 (03) : 463 - 469
  • [7] BRAF MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER: A POOLED ANALYSIS
    Huang, Zhi-min
    An, She J.
    Wu, Yi-long
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S458 - S458
  • [8] BRAF Mutations in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Chen, Dong
    Zhang, Li-Qun
    Huang, Jun-Fu
    Liu, Kai
    Chuai, Zheng-Ran
    Yang, Zhao
    Wang, Yun-Xia
    Shi, Da-Chuan
    Liu, Qian
    Huang, Qing
    Fu, Wei-Ling
    PLOS ONE, 2014, 9 (06):
  • [9] BRAF inhibitors in metastatic non-small cell lung cancer
    Anguera, Georgia
    Majem, Margarita
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 589 - 592
  • [10] Therapeutic strategies for BRAF mutation in non-small cell lung cancer: a review
    Puri, Megha
    Gawri, Kunal
    Dawar, Richa
    FRONTIERS IN ONCOLOGY, 2023, 13
12345